5 diabetes subgroups may have different comorbidities
Severe insulin-resistant and severe insulin-deficient patients could be targeted for prevention
A new study using five diabetes subgroups suggests patients in different groups face different comorbidities — a finding that could be used to improve prevention and treatment.
Last year, Swedish researchers reported that patients with diabetes could be classified into five subgroups with two broadly overlapping with type 1 diabetes, and the remaining three being more in line with type 2.
